While all Resolutions were passed with significant majorities, the Board notes that Resolutions 2 and 9 received less than 80% of votes cast in favor. The Board has consistently taken steps to ...

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to publish its Annual Report and Accounts and financial results for the year ended December ...

PureTech Health(NASDAQ:PRTC) reported its second quarter 2025 earnings on Aug. 28, 2025, highlighting a cash balance of just under $320 million at the end of the first half of 2025, a reduction in ...

PureTech Health (PRTC) announced the completion of the End-of-Phase 2 meeting with the FDA regarding the development of deupirfenidone, or ...

(RTTNews) - PureTech Health plc (PRTC, PRTC.L) announced Wednesday that Bharatt Chowrira has stepped down today from his role as Chief Executive Officer and as a member of the Board of Directors. The ...

The business has a fifty day moving average of $17.78 and a 200-day moving average of $18.06. An institutional investor recently raised its position in PureTech Health stock. Pentwater Capital ...

BOSTON--(BUSINESS WIRE)-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company") plans to announce its half-yearly results for the six months ended June 30, 2025, on Thursday, ...

The Annual General Meeting of PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech Health” or the “Company”) was held at 11 a.m. EDT/4 p.m. BST on Monday, June 16, 2025. All of the resolutions ...

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and ...